{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "new",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "11",
                "@timestamp": "2022-10-11T03:38:43.000043-04:00",
                "@year": "2022",
                "@month": "10"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2022",
                "@month": "09"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Chulalongkorn University",
                "xocs:funding-agency-acronym": "CU",
                "xocs:funding-agency": "Chulalongkorn University",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
            },
            "xocs:funding-addon-generated-timestamp": "2022-10-06T02:54:02.060Z",
            "xocs:funding-text": "This work was supported by the 90th Anniversary of Chulalongkorn University Scholarship Batch#41 (4/2018) Grant number 31. The funder had no role in any part of the work including design and conduct of the study, data collection, data management, data analysis and interpretation, preparation, review and approval of the manuscript.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Social and Administrative Pharmacy"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "108180929"
                            },
                            "@affiliation-instance-id": "2018099547-9e11e1f60e5e57e9ede150ade52a928a",
                            "ce:source-text": "Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.",
                            "@dptid": "108180929"
                        },
                        "author": [
                            {
                                "ce:given-name": "Chanthawat",
                                "preferred-name": {
                                    "ce:given-name": "Chanthawat",
                                    "ce:initials": "C.",
                                    "ce:surname": "Patikorn",
                                    "ce:indexed-name": "Patikorn C."
                                },
                                "@author-instance-id": "2018099547-336672d7bfc0723ec090dd7505919c2a",
                                "@seq": "1",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Patikorn",
                                "@auid": "57214073074",
                                "ce:indexed-name": "Patikorn C."
                            },
                            {
                                "ce:given-name": "Suthira",
                                "preferred-name": {
                                    "ce:given-name": "Suthira",
                                    "ce:initials": "S.",
                                    "ce:surname": "Taychakhoonavudh",
                                    "ce:indexed-name": "Taychakhoonavudh S."
                                },
                                "@author-instance-id": "2018099547-fdfadbe01fecf9724c84efc23f1146a8",
                                "@seq": "2",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Taychakhoonavudh",
                                "@auid": "56196894400",
                                "ce:indexed-name": "Taychakhoonavudh S."
                            },
                            {
                                "ce:given-name": "Rungpetch",
                                "preferred-name": {
                                    "ce:given-name": "Rungpetch",
                                    "ce:initials": "R.",
                                    "ce:surname": "Sakulbumrungsil",
                                    "ce:indexed-name": "Sakulbumrungsil R."
                                },
                                "@author-instance-id": "2018099547-3349bc76caf886f0758d803c02d4eb52",
                                "@seq": "3",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sakulbumrungsil",
                                "@auid": "23089392500",
                                "ce:indexed-name": "Sakulbumrungsil R."
                            },
                            {
                                "ce:given-name": "Puree",
                                "preferred-name": {
                                    "ce:given-name": "Puree",
                                    "ce:initials": "P.",
                                    "ce:surname": "Anantachoti",
                                    "ce:indexed-name": "Anantachoti P."
                                },
                                "@author-instance-id": "2018099547-9923d3cadd7a9742b8d647dd20ed668c",
                                "@seq": "5",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Anantachoti",
                                "@auid": "6506845858",
                                "ce:indexed-name": "Anantachoti P."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60104690",
                            "@country": "usa",
                            "city": "Boston",
                            "organization": [
                                {"$": "Department of Population Medicine"},
                                {"$": "Harvard Medical School and Harvard Pilgrim Health Care Institute"},
                                {"$": "Landmark Center"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60104690",
                                    "@dptid": "114546929"
                                },
                                {"@afid": "60002746"}
                            ],
                            "state": "MA",
                            "@affiliation-instance-id": "2018099547-26d63231ae23b90d5d616c44232c8efb",
                            "ce:source-text": "Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Landmark Center, Boston, MA, USA.",
                            "@dptid": "114546929"
                        },
                        "author": [{
                            "ce:given-name": "Dennis",
                            "preferred-name": {
                                "ce:given-name": "Dennis",
                                "ce:initials": "D.",
                                "ce:surname": "Ross-Degnan",
                                "ce:indexed-name": "Ross-Degnan D."
                            },
                            "@author-instance-id": "2018099547-4f5a2fe872cf5e500ab39d6bceafe9b5",
                            "@seq": "4",
                            "ce:initials": "D.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ross-Degnan",
                            "@auid": "7006679299",
                            "ce:indexed-name": "Ross-Degnan D."
                        }]
                    }
                ],
                "citation-title": "Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature",
                "abstracts": "Â© 2022 The Author(s); Published by Kerman University of Medical Sciences.Background: Each country manages access to anticancer drugs differently due to variations in the structure and financing of the health system, but a summary of the various strategies used is absent. This study aimed to review and summarize financing strategies implemented across countries to facilitate access to high-cost anticancer drugs. Methods: We conducted a systematic review of articles referenced in PubMed, Embase, and Web of Science through May 12, 2021. Articles published in the English language from 2000 that describe strategies implemented in different countries to facilitate access to high-cost anticancer drugs were included. Letters, news articles, and proposed strategies were excluded. Quality assessment was not performed as we aimed to summarize the strategies. Data were analyzed by thematic analysis. A review protocol was registered at PROSPERO (CRD42018068616). Results: The review included 204 studies from 176 countries. Three themes of financing strategies were identified: (1) Basic pharmaceutical reimbursement and pricing policies, (2) Alternative funding strategies specific to high-cost drugs, and (3) Financial assistance for individual patients. Access in most countries depends mainly on basic pharmaceutical reimbursement policies (165 of 176 countries). Apart from that, high-income countries (HICs) tended to use funding strategies targeting high-cost drugs (72% of HICs vs 0%-24% of the rest), such as managed entry agreements (MEAs) or dedicated funds for high-cost drugs. In contrast, lower-income countries tended to implement financial assistance programs for cancer patients as a tool to increase access (32% of HICs vs 62%-79% of the rest). Conclusion: Many countries have implemented a combination of strategies to increase access to high-cost anticancer drugs. Most low-and middle-income countries utilized placement of anticancer drugs on a national list of essential medicines and patient assistance programs (PAPs) to facilitate access, while many HICs implemented a broader range of strategies.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Department of Social and Administrative Pharmacy"},
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand."
                    },
                    "person": {
                        "ce:given-name": "Puree",
                        "ce:initials": "P.",
                        "ce:surname": "Anantachoti",
                        "ce:indexed-name": "Anantachoti P."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Antineoplastic Drug",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Expensive",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Reimbursement",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "re"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Int J Health Policy Manag",
                    "website": {"ce:e-address": {
                        "$": "www.ijhpm.com/",
                        "@type": "email"
                    }},
                    "@country": "irn",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": {
                        "$": "23225939",
                        "@type": "electronic"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "11",
                            "@issue": "9"
                        },
                        "pagerange": {
                            "@first": "1625",
                            "@last": "1634"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2022"},
                    "publisher": {"publishername": "Kerman University of Medical Sciences"},
                    "sourcetitle": "International Journal of Health Policy and Management",
                    "@srcid": "21100787828",
                    "publicationdate": {
                        "month": "09",
                        "year": "2022",
                        "date-text": "September 2022",
                        "day": "01"
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": [
                            {"$": "2911"},
                            {"$": "3306"},
                            {"$": "2719"},
                            {"$": "2308"},
                            {"$": "3605"}
                        ]
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": [
                            {"$": "NURS"},
                            {"$": "SOCI"},
                            {"$": "MEDI"},
                            {"$": "ENVI"},
                            {"$": "HEAL"}
                        ]
                    }
                ]}},
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This work was supported by the 90th Anniversary of Chulalongkorn University Scholarship Batch#41 (4/2018) Grant number 31. The funder had no role in any part of the work including design and conduct of the study, data collection, data management, data analysis and interpretation, preparation, review and approval of the manuscript.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-acronym": "CU",
                        "grant-agency": {
                            "@iso-code": "tha",
                            "$": "Chulalongkorn University"
                        },
                        "grant-agency-id": "501100002873"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "SNEMB"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "05",
                    "@timestamp": "BST 12:17:46",
                    "@year": "2022",
                    "@month": "10"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2018099547",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "943256275",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20222917631",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20223454866",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "2022144755",
                            "@idtype": "SNEMB"
                        },
                        {
                            "$": "20229016724982",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85139066866",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85139066866",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.34172/IJHPM.2021.138"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "45",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. doi:10.3322/caac.21492",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3322/caac.21492",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85053395052",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "68",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "394",
                                    "@last": "424"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Bray",
                                    "ce:indexed-name": "Bray F"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Ferlay",
                                    "ce:indexed-name": "Ferlay J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Soerjomataram",
                                    "ce:indexed-name": "Soerjomataram I"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "RL",
                                    "@_fa": "true",
                                    "ce:surname": "Siegel",
                                    "ce:indexed-name": "Siegel RL"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "LA",
                                    "@_fa": "true",
                                    "ce:surname": "Torre",
                                    "ce:indexed-name": "Torre LA"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jemal",
                                    "ce:indexed-name": "Jemal A."
                                }
                            ]},
                            "ref-sourcetitle": "CA Cancer J Clin"
                        },
                        "ce:source-text": "Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. doi:10.3322/caac.21492"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ruiz R, Strasser-Weippl K, Touya D, et al. Improving access to high-cost cancer drugs in Latin America: much to be done. Cancer. 2017; 123(8):1313-1323. doi:10.1002/cncr.30549",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Improving access to high-cost cancer drugs in Latin America: much to be done"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/cncr.30549",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85013374628",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "123",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1313",
                                    "@last": "1323"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Ruiz",
                                        "ce:indexed-name": "Ruiz R"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Strasser-Weippl",
                                        "ce:indexed-name": "Strasser-Weippl K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Touya",
                                        "ce:indexed-name": "Touya D"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer"
                        },
                        "ce:source-text": "Ruiz R, Strasser-Weippl K, Touya D, et al. Improving access to high-cost cancer drugs in Latin America: much to be done. Cancer. 2017; 123(8):1313-1323. doi:10.1002/cncr.30549"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27(23):3868-3874. doi:10.1200/jco.2009.23.1183",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "American Society of Clinical Oncology guidance statement: the cost of cancer care"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/jco.2009.23.1183",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "68949112230",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "23"
                                },
                                "pagerange": {
                                    "@first": "3868",
                                    "@last": "3874"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "NJ",
                                        "@_fa": "true",
                                        "ce:surname": "Meropol",
                                        "ce:indexed-name": "Meropol NJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Schrag",
                                        "ce:indexed-name": "Schrag D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "TJ",
                                        "@_fa": "true",
                                        "ce:surname": "Smith",
                                        "ce:indexed-name": "Smith TJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27(23):3868-3874. doi:10.1200/jco.2009.23.1183"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Leighl NB, Nirmalakumar S, Ezeife DA, Gyawali B. An arm and a leg: the rising cost of cancer drugs and impact on access. Am Soc Clin Oncol Educ Book. 2021;41:1-12. doi:10.1200/edbk_100028",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "An arm and a leg: the rising cost of cancer drugs and impact on access"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/edbk_100028",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85072246002",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "12"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "NB",
                                    "@_fa": "true",
                                    "ce:surname": "Leighl",
                                    "ce:indexed-name": "Leighl NB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Nirmalakumar",
                                    "ce:indexed-name": "Nirmalakumar S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "DA",
                                    "@_fa": "true",
                                    "ce:surname": "Ezeife",
                                    "ce:indexed-name": "Ezeife DA"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Gyawali",
                                    "ce:indexed-name": "Gyawali B."
                                }
                            ]},
                            "ref-sourcetitle": "Am Soc Clin Oncol Educ Book"
                        },
                        "ce:source-text": "Leighl NB, Nirmalakumar S, Ezeife DA, Gyawali B. An arm and a leg: the rising cost of cancer drugs and impact on access. Am Soc Clin Oncol Educ Book. 2021;41:1-12. doi:10.1200/edbk_100028"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "de Lima Lopes G Jr, de Souza JA, Barrios C. Access to cancer medications in low-and middle-income countries. Nat Rev Clin Oncol. 2013;10(6):314-322. doi:10.1038/nrclinonc.2013.55",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Access to cancer medications in low-and middle-income countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nrclinonc.2013.55",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84878528534",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "314",
                                    "@last": "322"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "de Lima Lopes",
                                    "ce:indexed-name": "de Lima Lopes G"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JA",
                                    "@_fa": "true",
                                    "ce:surname": "de Souza",
                                    "ce:indexed-name": "de Souza JA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Barrios",
                                    "ce:indexed-name": "Barrios C."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Clin Oncol"
                        },
                        "ce:source-text": "de Lima Lopes G Jr, de Souza JA, Barrios C. Access to cancer medications in low-and middle-income countries. Nat Rev Clin Oncol. 2013;10(6):314-322. doi:10.1038/nrclinonc.2013.55"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Patikorn C, Taychakhoonavudh S, Thathong T, Anantachoti P. Patient access to anticancer medicines under public health insurance schemes in Thailand: a mixed methods study. Thai J Pharm Sci. 2019;43(3):168-178.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Patient access to anticancer medicines under public health insurance schemes in Thailand: a mixed methods study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85078153573",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "43",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "168",
                                    "@last": "178"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Patikorn",
                                    "ce:indexed-name": "Patikorn C"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Taychakhoonavudh",
                                    "ce:indexed-name": "Taychakhoonavudh S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Thathong",
                                    "ce:indexed-name": "Thathong T"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Anantachoti",
                                    "ce:indexed-name": "Anantachoti P."
                                }
                            ]},
                            "ref-sourcetitle": "Thai J Pharm Sci"
                        },
                        "ce:source-text": "Patikorn C, Taychakhoonavudh S, Thathong T, Anantachoti P. Patient access to anticancer medicines under public health insurance schemes in Thailand: a mixed methods study. Thai J Pharm Sci. 2019;43(3):168-178."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ghinea N, Little M, Lipworth W. Access to high cost cancer medicines through the lens of an Australian senate inquiry-defining the \u201cgoods\u201d at stake. J Bioeth Inq. 2017;14(3):401-410. doi:10.1007/s11673-017-9800-2",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Access to high cost cancer medicines through the lens of an Australian senate inquiry-defining the \u201cgoods\u201d at stake"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11673-017-9800-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85024490360",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "14",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "401",
                                    "@last": "410"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Ghinea",
                                    "ce:indexed-name": "Ghinea N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Little",
                                    "ce:indexed-name": "Little M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Lipworth",
                                    "ce:indexed-name": "Lipworth W."
                                }
                            ]},
                            "ref-sourcetitle": "J Bioeth Inq"
                        },
                        "ce:source-text": "Ghinea N, Little M, Lipworth W. Access to high cost cancer medicines through the lens of an Australian senate inquiry-defining the \u201cgoods\u201d at stake. J Bioeth Inq. 2017;14(3):401-410. doi:10.1007/s11673-017-9800-2"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Faden RR, Chalkidou K, Appleby J, Waters HR, Leider JP. Expensive cancer drugs: a comparison between the United States and the United Kingdom. Milbank Q. 2009;87(4):789-819. doi:10.1111/j.1468-0009.2009.00579.x",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Expensive cancer drugs: a comparison between the United States and the United Kingdom"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/j.1468-0009.2009.00579.x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "72449203777",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "87",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "789",
                                    "@last": "819"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RR",
                                    "@_fa": "true",
                                    "ce:surname": "Faden",
                                    "ce:indexed-name": "Faden RR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Chalkidou",
                                    "ce:indexed-name": "Chalkidou K"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Appleby",
                                    "ce:indexed-name": "Appleby J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "HR",
                                    "@_fa": "true",
                                    "ce:surname": "Waters",
                                    "ce:indexed-name": "Waters HR"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "JP.",
                                    "@_fa": "true",
                                    "ce:surname": "Leider",
                                    "ce:indexed-name": "Leider JP."
                                }
                            ]},
                            "ref-sourcetitle": "Milbank Q"
                        },
                        "ce:source-text": "Faden RR, Chalkidou K, Appleby J, Waters HR, Leider JP. Expensive cancer drugs: a comparison between the United States and the United Kingdom. Milbank Q. 2009;87(4):789-819. doi:10.1111/j.1468-0009.2009.00579.x"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AK. Policies and programs to facilitate access to targeted cancer therapies in Thailand. PLoS One. 2015;10(3):e0119945. doi:10.1371/journal. pone.0119945",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Policies and programs to facilitate access to targeted cancer therapies in Thailand"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0119945",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84925710787",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "e0119945"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Sruamsiri",
                                    "ce:indexed-name": "Sruamsiri R"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Ross-Degnan",
                                    "ce:indexed-name": "Ross-Degnan D"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "CY",
                                    "@_fa": "true",
                                    "ce:surname": "Lu",
                                    "ce:indexed-name": "Lu CY"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Chaiyakunapruk",
                                    "ce:indexed-name": "Chaiyakunapruk N"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "AK.",
                                    "@_fa": "true",
                                    "ce:surname": "Wagner",
                                    "ce:indexed-name": "Wagner AK."
                                }
                            ]},
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Sruamsiri R, Ross-Degnan D, Lu CY, Chaiyakunapruk N, Wagner AK. Policies and programs to facilitate access to targeted cancer therapies in Thailand. PLoS One. 2015;10(3):e0119945. doi:10.1371/journal. pone.0119945"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Pauwels K, Huys I, Casteels M, De Nys K, Simoens S. Market access of cancer drugs in European countries: improving resource allocation. Target Oncol. 2014;9(2):95-110. doi:10.1007/s11523-013-0301-x",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Market access of cancer drugs in European countries: improving resource allocation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11523-013-0301-x",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84902547987",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "95",
                                    "@last": "110"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Pauwels",
                                    "ce:indexed-name": "Pauwels K"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Huys",
                                    "ce:indexed-name": "Huys I"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Casteels",
                                    "ce:indexed-name": "Casteels M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "De Nys",
                                    "ce:indexed-name": "De Nys K"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Simoens",
                                    "ce:indexed-name": "Simoens S."
                                }
                            ]},
                            "ref-sourcetitle": "Target Oncol"
                        },
                        "ce:source-text": "Pauwels K, Huys I, Casteels M, De Nys K, Simoens S. Market access of cancer drugs in European countries: improving resource allocation. Target Oncol. 2014;9(2):95-110. doi:10.1007/s11523-013-0301-x"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. doi:10.1136/bmj.n71",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "The PRISMA 2020 statement: an updated guideline for reporting systematic reviews"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1136/bmj.n71",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85103451714",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "372"},
                                "pagerange": {"@first": "n71"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MJ",
                                        "@_fa": "true",
                                        "ce:surname": "Page",
                                        "ce:indexed-name": "Page MJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "JE",
                                        "@_fa": "true",
                                        "ce:surname": "McKenzie",
                                        "ce:indexed-name": "McKenzie JE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "PM",
                                        "@_fa": "true",
                                        "ce:surname": "Bossuyt",
                                        "ce:indexed-name": "Bossuyt PM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMJ"
                        },
                        "ce:source-text": "Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. doi:10.1136/bmj.n71"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "World Bank. World Bank Country and Lending Groups. 2021; https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed May 27, 2021.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85106437255",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed May 27, 2021",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "World Bank",
                                "ce:indexed-name": "World Bank"
                            }},
                            "ref-sourcetitle": "World Bank Country and Lending Groups"
                        },
                        "ce:source-text": "World Bank. World Bank Country and Lending Groups. 2021; https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed May 27, 2021."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Cherny N, Sullivan R, Torode J, Saar M, Eniu A. ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. Ann Oncol. 2016;27(8):1423-1443. doi:10.1093/annonc/mdw213",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdw213",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84984984313",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "27",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1423",
                                    "@last": "1443"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Cherny",
                                    "ce:indexed-name": "Cherny N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Sullivan",
                                    "ce:indexed-name": "Sullivan R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Torode",
                                    "ce:indexed-name": "Torode J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Saar",
                                    "ce:indexed-name": "Saar M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Eniu",
                                    "ce:indexed-name": "Eniu A."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Cherny N, Sullivan R, Torode J, Saar M, Eniu A. ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. Ann Oncol. 2016;27(8):1423-1443. doi:10.1093/annonc/mdw213"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Cherny NI, Sullivan R, Torode J, Saar M, Eniu A. ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe. Ann Oncol. 2017;28(11):2633-2647. doi:10.1093/annonc/mdx521",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdx521",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85034028623",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "2633",
                                    "@last": "2647"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "NI",
                                    "@_fa": "true",
                                    "ce:surname": "Cherny",
                                    "ce:indexed-name": "Cherny NI"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Sullivan",
                                    "ce:indexed-name": "Sullivan R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Torode",
                                    "ce:indexed-name": "Torode J"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Saar",
                                    "ce:indexed-name": "Saar M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Eniu",
                                    "ce:indexed-name": "Eniu A."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Cherny NI, Sullivan R, Torode J, Saar M, Eniu A. ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe. Ann Oncol. 2017;28(11):2633-2647. doi:10.1093/annonc/mdx521"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Cuomo RE, Mackey TK. The availability of essential cancer medication: an analysis of national formularies. J Cancer Policy. 2017;12:49-54. doi:10.1016/j.jcpo.2017.03.010",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The availability of essential cancer medication: an analysis of national formularies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jcpo.2017.03.010",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85016258176",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "49",
                                    "@last": "54"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RE",
                                    "@_fa": "true",
                                    "ce:surname": "Cuomo",
                                    "ce:indexed-name": "Cuomo RE"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "TK.",
                                    "@_fa": "true",
                                    "ce:surname": "Mackey",
                                    "ce:indexed-name": "Mackey TK."
                                }
                            ]},
                            "ref-sourcetitle": "J Cancer Policy"
                        },
                        "ce:source-text": "Cuomo RE, Mackey TK. The availability of essential cancer medication: an analysis of national formularies. J Cancer Policy. 2017;12:49-54. doi:10.1016/j.jcpo.2017.03.010"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Shafie AA, Chandriah H. Access to cancer drugs: are we meeting the needs of Malaysian? J Cancer Policy. 2017;13:30-32. doi:10.1016/j. jcpo.2017.07.003",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Access to cancer drugs: are we meeting the needs of Malaysian?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jcpo.2017.07.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85030704882",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "30",
                                    "@last": "32"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AA",
                                    "@_fa": "true",
                                    "ce:surname": "Shafie",
                                    "ce:indexed-name": "Shafie AA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Chandriah",
                                    "ce:indexed-name": "Chandriah H."
                                }
                            ]},
                            "ref-sourcetitle": "J Cancer Policy"
                        },
                        "ce:source-text": "Shafie AA, Chandriah H. Access to cancer drugs: are we meeting the needs of Malaysian? J Cancer Policy. 2017;13:30-32. doi:10.1016/j. jcpo.2017.07.003"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Milliken D, Venkatesh J, Yu R, Su Z, Thompson M, Eurich D. Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance. BMJ Open. 2015;5(9):e008100. doi:10.1136/bmjopen-2015-008100",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1136/bmjopen-2015-008100",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84947758482",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "9"
                                },
                                "pagerange": {"@first": "e008100"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Milliken",
                                    "ce:indexed-name": "Milliken D"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Venkatesh",
                                    "ce:indexed-name": "Venkatesh J"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Yu",
                                    "ce:indexed-name": "Yu R"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Z",
                                    "@_fa": "true",
                                    "ce:surname": "Su",
                                    "ce:indexed-name": "Su Z"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Thompson",
                                    "ce:indexed-name": "Thompson M"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Eurich",
                                    "ce:indexed-name": "Eurich D."
                                }
                            ]},
                            "ref-sourcetitle": "BMJ Open"
                        },
                        "ce:source-text": "Milliken D, Venkatesh J, Yu R, Su Z, Thompson M, Eurich D. Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance. BMJ Open. 2015;5(9):e008100. doi:10.1136/bmjopen-2015-008100"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol. 2014; 15(5):489-538. doi:10.1016/s1470-2045(14)70029-4",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Challenges to effective cancer control in China, India, and Russia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/s1470-2045(14)70029-4",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84898041689",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "489",
                                    "@last": "538"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PE",
                                        "@_fa": "true",
                                        "ce:surname": "Goss",
                                        "ce:indexed-name": "Goss PE"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Strasser-Weippl",
                                        "ce:indexed-name": "Strasser-Weippl K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "BL",
                                        "@_fa": "true",
                                        "ce:surname": "Lee-Bychkovsky",
                                        "ce:indexed-name": "Lee-Bychkovsky BL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol. 2014; 15(5):489-538. doi:10.1016/s1470-2045(14)70029-4"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Menon D, Stafinski T, Stuart G. Access to drugs for cancer: does where you live matter? Can J Public Health. 2005;96(6):454-458. doi:10.1007/bf03405189",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Access to drugs for cancer: does where you live matter?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/bf03405189",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "28844479957",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "96",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "454",
                                    "@last": "458"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Menon",
                                    "ce:indexed-name": "Menon D"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Stafinski",
                                    "ce:indexed-name": "Stafinski T"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Stuart",
                                    "ce:indexed-name": "Stuart G."
                                }
                            ]},
                            "ref-sourcetitle": "Can J Public Health"
                        },
                        "ce:source-text": "Menon D, Stafinski T, Stuart G. Access to drugs for cancer: does where you live matter? Can J Public Health. 2005;96(6):454-458. doi:10.1007/bf03405189"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "World Health Organization (WHO). WHO Model List of Essential Medicines, 20th list (March 2017, Amended August 2017). WHO; 2017.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33749252978",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "(March Amended August 2017). WHO; 2017",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "World Health Organization (WHO)",
                                "ce:indexed-name": "World Health Organization (WHO)"
                            }},
                            "ref-sourcetitle": "WHO Model List of Essential Medicines, 20th list"
                        },
                        "ce:source-text": "World Health Organization (WHO). WHO Model List of Essential Medicines, 20th list (March 2017, Amended August 2017). WHO; 2017."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Neumann PJ, Bliss SK, Chambers JD. Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries. Health Aff (Millwood). 2012;31(4):700-708. doi:10.1377/hlthaff.2011.1309",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1377/hlthaff.2011.1309",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84862490914",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "31",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "700",
                                    "@last": "708"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "PJ",
                                    "@_fa": "true",
                                    "ce:surname": "Neumann",
                                    "ce:indexed-name": "Neumann PJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "SK",
                                    "@_fa": "true",
                                    "ce:surname": "Bliss",
                                    "ce:indexed-name": "Bliss SK"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "JD.",
                                    "@_fa": "true",
                                    "ce:surname": "Chambers",
                                    "ce:indexed-name": "Chambers JD."
                                }
                            ]},
                            "ref-sourcetitle": "Health Aff (Millwood)"
                        },
                        "ce:source-text": "Neumann PJ, Bliss SK, Chambers JD. Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries. Health Aff (Millwood). 2012;31(4):700-708. doi:10.1377/hlthaff.2011.1309"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Karikios DJ, Chim L, Martin A, et al. Is it all about price? why requests for government subsidy of anticancer drugs were rejected in Australia. Intern Med J. 2017;47(4):400-407. doi:10.1111/imj.13350",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Is it all about price? why requests for government subsidy of anticancer drugs were rejected in Australia"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/imj.13350",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85017287879",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "47",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "400",
                                    "@last": "407"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DJ",
                                        "@_fa": "true",
                                        "ce:surname": "Karikios",
                                        "ce:indexed-name": "Karikios DJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Chim",
                                        "ce:indexed-name": "Chim L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Martin",
                                        "ce:indexed-name": "Martin A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Intern Med J"
                        },
                        "ce:source-text": "Karikios DJ, Chim L, Martin A, et al. Is it all about price? why requests for government subsidy of anticancer drugs were rejected in Australia. Intern Med J. 2017;47(4):400-407. doi:10.1111/imj.13350"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Kim ES, Kim JA, Lee EK. National reimbursement listing determinants of new cancer drugs: a retrospective analysis of 58 cancer treatment appraisals in 2007-2016 in South Korea. Expert Rev Pharmacoecon Outcomes Res. 2017;17(4):401-409. doi:10.1080/14737167.2017.1276 828",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "National reimbursement listing determinants of new cancer drugs: a retrospective analysis of 58 cancer treatment appraisals in 2007-2016 in South Korea"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/14737167.2017.1276828",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85008223818",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "401",
                                    "@last": "409"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "ES",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim ES"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JA",
                                    "@_fa": "true",
                                    "ce:surname": "Kim",
                                    "ce:indexed-name": "Kim JA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "EK.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee EK."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Pharmacoecon Outcomes Res"
                        },
                        "ce:source-text": "Kim ES, Kim JA, Lee EK. National reimbursement listing determinants of new cancer drugs: a retrospective analysis of 58 cancer treatment appraisals in 2007-2016 in South Korea. Expert Rev Pharmacoecon Outcomes Res. 2017;17(4):401-409. doi:10.1080/14737167.2017.1276 828"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ferrario A. Time to entry for new cancer medicines: from European Union-wide marketing authorization to patient Access in Belgium, Estonia, Scotland, and Sweden. Value Health. 2018;21(7):809-821. doi:10.1016/j. jval.2018.01.003",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Time to entry for new cancer medicines: from European Union-wide marketing authorization to patient Access in Belgium, Estonia, Scotland, and Sweden"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jval.2018.01.003",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85044297330",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "809",
                                    "@last": "821"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Ferrario",
                                "ce:indexed-name": "Ferrario A."
                            }]},
                            "ref-sourcetitle": "Value Health"
                        },
                        "ce:source-text": "Ferrario A. Time to entry for new cancer medicines: from European Union-wide marketing authorization to patient Access in Belgium, Estonia, Scotland, and Sweden. Value Health. 2018;21(7):809-821. doi:10.1016/j. jval.2018.01.003"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "McGuire A, Drummond M, Martin M, Justo N. End of life or end of the road? are rising cancer costs sustainable? is it time to consider alternative incentive and funding schemes? Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):599-605. doi:10.1586/14737167.2015.1039518",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "End of life or end of the road? are rising cancer costs sustainable? is it time to consider alternative incentive and funding schemes?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1586/14737167.2015.1039518",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84945952921",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "599",
                                    "@last": "605"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "McGuire",
                                    "ce:indexed-name": "McGuire A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Drummond",
                                    "ce:indexed-name": "Drummond M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Martin",
                                    "ce:indexed-name": "Martin M"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Justo",
                                    "ce:indexed-name": "Justo N."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Pharmacoecon Outcomes Res"
                        },
                        "ce:source-text": "McGuire A, Drummond M, Martin M, Justo N. End of life or end of the road? are rising cancer costs sustainable? is it time to consider alternative incentive and funding schemes? Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):599-605. doi:10.1586/14737167.2015.1039518"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Russo P, Mennini FS, Siviero PD, Rasi G. Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers. Ann Oncol. 2010; 21(10):2081-2087. doi:10.1093/annonc/mdq097",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdq097",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "77957123635",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "10"
                                },
                                "pagerange": {
                                    "@first": "2081",
                                    "@last": "2087"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Russo",
                                    "ce:indexed-name": "Russo P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "FS",
                                    "@_fa": "true",
                                    "ce:surname": "Mennini",
                                    "ce:indexed-name": "Mennini FS"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "PD",
                                    "@_fa": "true",
                                    "ce:surname": "Siviero",
                                    "ce:indexed-name": "Siviero PD"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Rasi",
                                    "ce:indexed-name": "Rasi G."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Russo P, Mennini FS, Siviero PD, Rasi G. Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers. Ann Oncol. 2010; 21(10):2081-2087. doi:10.1093/annonc/mdq097"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Pauwels K, Huys I, Vogler S, Casteels M, Simoens S. Managed entry agreements for oncology drugs: lessons from the european experience to inform the future. Front Pharmacol. 2017;8:171. doi:10.3389/fphar.2017.00171",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Managed entry agreements for oncology drugs: lessons from the european experience to inform the future"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fphar.2017.00171",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85018384674",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "171"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Pauwels",
                                    "ce:indexed-name": "Pauwels K"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Huys",
                                    "ce:indexed-name": "Huys I"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Vogler",
                                    "ce:indexed-name": "Vogler S"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Casteels",
                                    "ce:indexed-name": "Casteels M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Simoens",
                                    "ce:indexed-name": "Simoens S."
                                }
                            ]},
                            "ref-sourcetitle": "Front Pharmacol"
                        },
                        "ce:source-text": "Pauwels K, Huys I, Vogler S, Casteels M, Simoens S. Managed entry agreements for oncology drugs: lessons from the european experience to inform the future. Front Pharmacol. 2017;8:171. doi:10.3389/fphar.2017.00171"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Cohen J, Malins A, Shahpurwala Z. Compared to US practice, evidence-based reviews in Europe appear to lead to lower prices for some drugs. Health Aff (Millwood). 2013;32(4):762-770. doi:10.1377/hlthaff.2012.0707",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Compared to US practice, evidence-based reviews in Europe appear to lead to lower prices for some drugs"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1377/hlthaff.2012.0707",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84877979268",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "32",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "762",
                                    "@last": "770"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Cohen",
                                    "ce:indexed-name": "Cohen J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Malins",
                                    "ce:indexed-name": "Malins A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Shahpurwala",
                                    "ce:indexed-name": "Shahpurwala Z."
                                }
                            ]},
                            "ref-sourcetitle": "Health Aff (Millwood)"
                        },
                        "ce:source-text": "Cohen J, Malins A, Shahpurwala Z. Compared to US practice, evidence-based reviews in Europe appear to lead to lower prices for some drugs. Health Aff (Millwood). 2013;32(4):762-770. doi:10.1377/hlthaff.2012.0707"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "MihajloviÄ J, Dolk C, Tolley K, Simoens S, Postma MJ. Reimbursement of targeted cancer therapies within 3 different European health care systems. Clin Ther. 2015;37(2):474-480. doi:10.1016/j.clinthera.2014.12.005",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Reimbursement of targeted cancer therapies within 3 different European health care systems"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.clinthera.2014.12.005",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84923642755",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "37",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "474",
                                    "@last": "480"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "MihajloviÄ",
                                    "ce:indexed-name": "Mihajlovic J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Dolk",
                                    "ce:indexed-name": "Dolk C"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K",
                                    "@_fa": "true",
                                    "ce:surname": "Tolley",
                                    "ce:indexed-name": "Tolley K"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Simoens",
                                    "ce:indexed-name": "Simoens S"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "MJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Postma",
                                    "ce:indexed-name": "Postma MJ."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Ther"
                        },
                        "ce:source-text": "MihajloviÄ J, Dolk C, Tolley K, Simoens S, Postma MJ. Reimbursement of targeted cancer therapies within 3 different European health care systems. Clin Ther. 2015;37(2):474-480. doi:10.1016/j.clinthera.2014.12.005"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Ferrario A, ArÄja D, Bochenek T, et al. The implementation of managed entry agreements in Central and Eastern Europe: Findings and Implications. Pharmacoeconomics. 2017;35(12):1271-1285. doi:10.1007/s40273-017-0559-4",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The implementation of managed entry agreements in Central and Eastern Europe: Findings and Implications"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s40273-017-0559-4",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85028005939",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "35",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1271",
                                    "@last": "1285"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrario",
                                        "ce:indexed-name": "Ferrario A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "ArÄja",
                                        "ce:indexed-name": "Araja D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Bochenek",
                                        "ce:indexed-name": "Bochenek T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Pharmacoeconomics"
                        },
                        "ce:source-text": "Ferrario A, ArÄja D, Bochenek T, et al. The implementation of managed entry agreements in Central and Eastern Europe: Findings and Implications. Pharmacoeconomics. 2017;35(12):1271-1285. doi:10.1007/s40273-017-0559-4"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Grover P, Babar ZU, Oehmen R, Vitry A. Medicines access programs to cancer medicines in Australia and New Zealand: an exploratory study. Health Policy. 2018;122(3):243-249. doi:10.1016/j.healthpol.2017.12.004",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Medicines access programs to cancer medicines in Australia and New Zealand: an exploratory study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.healthpol.2017.12.004",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85039724620",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "122",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "243",
                                    "@last": "249"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Grover",
                                    "ce:indexed-name": "Grover P"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "ZU",
                                    "@_fa": "true",
                                    "ce:surname": "Babar",
                                    "ce:indexed-name": "Babar ZU"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Oehmen",
                                    "ce:indexed-name": "Oehmen R"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Vitry",
                                    "ce:indexed-name": "Vitry A."
                                }
                            ]},
                            "ref-sourcetitle": "Health Policy"
                        },
                        "ce:source-text": "Grover P, Babar ZU, Oehmen R, Vitry A. Medicines access programs to cancer medicines in Australia and New Zealand: an exploratory study. Health Policy. 2018;122(3):243-249. doi:10.1016/j.healthpol.2017.12.004"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Blommestein HM, Franken MG, Verelst SG, van Agthoven M, Huijgens PC, Uyl-de Groot CA. Access to expensive cancer drugs in Dutch daily practice: should we be concerned? Neth J Med. 2014;72(4):235-241.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Access to expensive cancer drugs in Dutch daily practice: should we be concerned?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84897108927",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "72",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "235",
                                    "@last": "241"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "HM",
                                    "@_fa": "true",
                                    "ce:surname": "Blommestein",
                                    "ce:indexed-name": "Blommestein HM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "MG",
                                    "@_fa": "true",
                                    "ce:surname": "Franken",
                                    "ce:indexed-name": "Franken MG"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "SG",
                                    "@_fa": "true",
                                    "ce:surname": "Verelst",
                                    "ce:indexed-name": "Verelst SG"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "van Agthoven",
                                    "ce:indexed-name": "van Agthoven M"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "PC",
                                    "@_fa": "true",
                                    "ce:surname": "Huijgens",
                                    "ce:indexed-name": "Huijgens PC"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "CA.",
                                    "@_fa": "true",
                                    "ce:surname": "Uyl-de Groot",
                                    "ce:indexed-name": "Uyl-de Groot CA."
                                }
                            ]},
                            "ref-sourcetitle": "Neth J Med"
                        },
                        "ce:source-text": "Blommestein HM, Franken MG, Verelst SG, van Agthoven M, Huijgens PC, Uyl-de Groot CA. Access to expensive cancer drugs in Dutch daily practice: should we be concerned? Neth J Med. 2014;72(4):235-241."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Pace J, Ghinea N, Kerridge I, Lipworth W. Demands for access to new therapies: are there alternatives to accelerated access? BMJ. 2017; 359:j4494. doi:10.1136/bmj.j4494",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Demands for access to new therapies: are there alternatives to accelerated access?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1136/bmj.j4494",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85030692318",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {"@first": "j4494"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Pace",
                                    "ce:indexed-name": "Pace J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Ghinea",
                                    "ce:indexed-name": "Ghinea N"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Kerridge",
                                    "ce:indexed-name": "Kerridge I"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Lipworth",
                                    "ce:indexed-name": "Lipworth W."
                                }
                            ]},
                            "ref-sourcetitle": "BMJ"
                        },
                        "ce:source-text": "Pace J, Ghinea N, Kerridge I, Lipworth W. Demands for access to new therapies: are there alternatives to accelerated access? BMJ. 2017; 359:j4494. doi:10.1136/bmj.j4494"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Zhang Y, Hueser HC, Hernandez I. Comparing the approval and coverage decisions of new oncology drugs in the United States and other selected countries. J Manag Care Spec Pharm. 2017;23(2):247-254. doi:10.18553/jmcp.2017.23.2.247",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Comparing the approval and coverage decisions of new oncology drugs in the United States and other selected countries"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.18553/jmcp.2017.23.2.247",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85011019551",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "247",
                                    "@last": "254"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Y",
                                    "@_fa": "true",
                                    "ce:surname": "Zhang",
                                    "ce:indexed-name": "Zhang Y"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "HC",
                                    "@_fa": "true",
                                    "ce:surname": "Hueser",
                                    "ce:indexed-name": "Hueser HC"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "Hernandez",
                                    "ce:indexed-name": "Hernandez I."
                                }
                            ]},
                            "ref-sourcetitle": "J Manag Care Spec Pharm"
                        },
                        "ce:source-text": "Zhang Y, Hueser HC, Hernandez I. Comparing the approval and coverage decisions of new oncology drugs in the United States and other selected countries. J Manag Care Spec Pharm. 2017;23(2):247-254. doi:10.18553/jmcp.2017.23.2.247"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Morrell L, Wordsworth S, Fu H, Rees S, Barker R. Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes. BMC Health Serv Res. 2017;17(1):613. doi:10.1186/s12913-017-2561-0",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s12913-017-2561-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85028641605",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "613"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Morrell",
                                    "ce:indexed-name": "Morrell L"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Wordsworth",
                                    "ce:indexed-name": "Wordsworth S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Fu",
                                    "ce:indexed-name": "Fu H"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Rees",
                                    "ce:indexed-name": "Rees S"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Barker",
                                    "ce:indexed-name": "Barker R."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Health Serv Res"
                        },
                        "ce:source-text": "Morrell L, Wordsworth S, Fu H, Rees S, Barker R. Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes. BMC Health Serv Res. 2017;17(1):613. doi:10.1186/s12913-017-2561-0"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "LÃ¶blovÃ¡ O, CsanÃ¡di M, OzieraÅski P, KalÃ³ Z, King L, McKee M. Patterns of alternative access: unpacking the Slovak extraordinary drug reimbursement regime 2012-2016. Health Policy. 2019;123(8):713-720. doi:10.1016/j.healthpol.2019.05.021",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Patterns of alternative access: unpacking the Slovak extraordinary drug reimbursement regime 2012-2016"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.healthpol.2019.05.021",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85068227007",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "123",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "713",
                                    "@last": "720"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "O",
                                    "@_fa": "true",
                                    "ce:surname": "LÃ¶blovÃ¡",
                                    "ce:indexed-name": "Loblova O"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "CsanÃ¡di",
                                    "ce:indexed-name": "Csanadi M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "OzieraÅski",
                                    "ce:indexed-name": "Ozieranski P"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Z",
                                    "@_fa": "true",
                                    "ce:surname": "KalÃ³",
                                    "ce:indexed-name": "Kalo Z"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "King",
                                    "ce:indexed-name": "King L"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "McKee",
                                    "ce:indexed-name": "McKee M."
                                }
                            ]},
                            "ref-sourcetitle": "Health Policy"
                        },
                        "ce:source-text": "LÃ¶blovÃ¡ O, CsanÃ¡di M, OzieraÅski P, KalÃ³ Z, King L, McKee M. Patterns of alternative access: unpacking the Slovak extraordinary drug reimbursement regime 2012-2016. Health Policy. 2019;123(8):713-720. doi:10.1016/j.healthpol.2019.05.021"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "den Exter A. Fighting excessive pharmaceutical prices: evaluating the options. Eur J Health Law. 2020;28(1):68-80. doi:10.1163/15718093-bja10004",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Fighting excessive pharmaceutical prices: evaluating the options"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1163/15718093-bja10004",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85102482446",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "28",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "68",
                                    "@last": "80"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "den Exter",
                                "ce:indexed-name": "den Exter A."
                            }]},
                            "ref-sourcetitle": "Eur J Health Law"
                        },
                        "ce:source-text": "den Exter A. Fighting excessive pharmaceutical prices: evaluating the options. Eur J Health Law. 2020;28(1):68-80. doi:10.1163/15718093-bja10004"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Haitsma G, Patel H, Gurumurthy P, Postma MJ. Access to anti-cancer drugs in India: is there a need to revise reimbursement policies? Expert Rev Pharmacoecon Outcomes Res. 2018;18(3):289-296. doi:10.1080/14 737167.2018.1444479",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Access to anti-cancer drugs in India: is there a need to revise reimbursement policies?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1080/14737167.2018.1444479",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85042934846",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "289",
                                    "@last": "296"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G",
                                    "@_fa": "true",
                                    "ce:surname": "Haitsma",
                                    "ce:indexed-name": "Haitsma G"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel H"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Gurumurthy",
                                    "ce:indexed-name": "Gurumurthy P"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "MJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Postma",
                                    "ce:indexed-name": "Postma MJ."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Rev Pharmacoecon Outcomes Res"
                        },
                        "ce:source-text": "Haitsma G, Patel H, Gurumurthy P, Postma MJ. Access to anti-cancer drugs in India: is there a need to revise reimbursement policies? Expert Rev Pharmacoecon Outcomes Res. 2018;18(3):289-296. doi:10.1080/14 737167.2018.1444479"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Dusetzina SB, Keating NL. Mind the gap: why closing the doughnut hole is insufficient for increasing Medicare beneficiary access to oral chemotherapy. J Clin Oncol. 2016;34(4):375-380. doi:10.1200/jco.2015.63.7736",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Mind the gap: why closing the doughnut hole is insufficient for increasing Medicare beneficiary access to oral chemotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/jco.2015.63.7736",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84955588119",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "34",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "375",
                                    "@last": "380"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "SB",
                                    "@_fa": "true",
                                    "ce:surname": "Dusetzina",
                                    "ce:indexed-name": "Dusetzina SB"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "NL.",
                                    "@_fa": "true",
                                    "ce:surname": "Keating",
                                    "ce:indexed-name": "Keating NL."
                                }
                            ]},
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Dusetzina SB, Keating NL. Mind the gap: why closing the doughnut hole is insufficient for increasing Medicare beneficiary access to oral chemotherapy. J Clin Oncol. 2016;34(4):375-380. doi:10.1200/jco.2015.63.7736"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lassarat S, Jootar S. Ongoing challenges of a global international patient assistance program. Ann Oncol. 2006;17 Suppl 8:viii43-viii46. doi:10.1093/annonc/mdl987",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Ongoing challenges of a global international patient assistance program"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdl987",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "33745608999",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "viii43",
                                    "@last": "viii46"
                                }
                            },
                            "ref-text": "Suppl 8",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Lassarat",
                                    "ce:indexed-name": "Lassarat S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Jootar",
                                    "ce:indexed-name": "Jootar S."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Lassarat S, Jootar S. Ongoing challenges of a global international patient assistance program. Ann Oncol. 2006;17 Suppl 8:viii43-viii46. doi:10.1093/annonc/mdl987"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Umeh CA, Garcia-Gonzalez P, Tremblay D, Laing R. The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP). EClinicalMedicine. 2020;19:100257. doi:10.1016/j.eclinm.2020.100257",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.eclinm.2020.100257",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85078177665",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {"@first": "100257"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "CA",
                                    "@_fa": "true",
                                    "ce:surname": "Umeh",
                                    "ce:indexed-name": "Umeh CA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Garcia-Gonzalez",
                                    "ce:indexed-name": "Garcia-Gonzalez P"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Tremblay",
                                    "ce:indexed-name": "Tremblay D"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Laing",
                                    "ce:indexed-name": "Laing R."
                                }
                            ]},
                            "ref-sourcetitle": "EClinicalMedicine"
                        },
                        "ce:source-text": "Umeh CA, Garcia-Gonzalez P, Tremblay D, Laing R. The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP). EClinicalMedicine. 2020;19:100257. doi:10.1016/j.eclinm.2020.100257"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lee AW, Sze H, Lam KO, Chen X. A tale of two cities in China: Hong Kong and Shenzhen. Int J Radiat Oncol Biol Phys. 2014;89(4):704-708. doi:10.1016/j.ijrobp.2013.12.053",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "A tale of two cities in China: Hong Kong and Shenzhen"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.ijrobp.2013.12.053",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84903192764",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "89",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "704",
                                    "@last": "708"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AW",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee AW"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Sze",
                                    "ce:indexed-name": "Sze H"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "KO",
                                    "@_fa": "true",
                                    "ce:surname": "Lam",
                                    "ce:indexed-name": "Lam KO"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen X."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Radiat Oncol Biol Phys"
                        },
                        "ce:source-text": "Lee AW, Sze H, Lam KO, Chen X. A tale of two cities in China: Hong Kong and Shenzhen. Int J Radiat Oncol Biol Phys. 2014;89(4):704-708. doi:10.1016/j.ijrobp.2013.12.053"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Egerton NJ. In-office dispensing of oral oncolytics: a continuity of care and cost mitigation model for cancer patients. Am J Manag Care. 2016;22(4 Suppl):S99-S103.",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "In-office dispensing of oral oncolytics: a continuity of care and cost mitigation model for cancer patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84979787529",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "22",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "S99",
                                    "@last": "S103"
                                }
                            },
                            "ref-text": "(Suppl)",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "NJ.",
                                "@_fa": "true",
                                "ce:surname": "Egerton",
                                "ce:indexed-name": "Egerton NJ."
                            }]},
                            "ref-sourcetitle": "Am J Manag Care"
                        },
                        "ce:source-text": "Egerton NJ. In-office dispensing of oral oncolytics: a continuity of care and cost mitigation model for cancer patients. Am J Manag Care. 2016;22(4 Suppl):S99-S103."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Mitchell A, Muluneh B, Patel R, Basch E. Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics. J Oncol Pharm Pract. 2018;24(6):424-432. doi:10.1177/1078155217719585",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/1078155217719585",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85051790500",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "424",
                                    "@last": "432"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Mitchell",
                                    "ce:indexed-name": "Mitchell A"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B",
                                    "@_fa": "true",
                                    "ce:surname": "Muluneh",
                                    "ce:indexed-name": "Muluneh B"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel R"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Basch",
                                    "ce:indexed-name": "Basch E."
                                }
                            ]},
                            "ref-sourcetitle": "J Oncol Pharm Pract"
                        },
                        "ce:source-text": "Mitchell A, Muluneh B, Patel R, Basch E. Pharmaceutical assistance programs for cancer patients in the era of orally administered chemotherapeutics. J Oncol Pharm Pract. 2018;24(6):424-432. doi:10.1177/1078155217719585"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.225",
                        "ref-fulltext": "Lakdawalla DN, Doshi JA, Garrison LP Jr, Phelps CE, Basu A, Danzon PM. Defining elements of value in health care-a health economics approach: an ISPOR Special Task Force report [3]. Value Health. 2018;21(2):131-139. doi:10.1016/j.jval.2017.12.007",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Defining elements of value in health care-a health economics approach: an ISPOR Special Task Force report [3]"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jval.2017.12.007",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85042255252",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "131",
                                    "@last": "139"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "DN",
                                    "@_fa": "true",
                                    "ce:surname": "Lakdawalla",
                                    "ce:indexed-name": "Lakdawalla DN"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JA",
                                    "@_fa": "true",
                                    "ce:surname": "Doshi",
                                    "ce:indexed-name": "Doshi JA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "LP",
                                    "@_fa": "true",
                                    "ce:surname": "Garrison",
                                    "ce:indexed-name": "Garrison LP"
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "CE",
                                    "@_fa": "true",
                                    "ce:surname": "Phelps",
                                    "ce:indexed-name": "Phelps CE"
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Basu",
                                    "ce:indexed-name": "Basu A"
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "PM.",
                                    "@_fa": "true",
                                    "ce:surname": "Danzon",
                                    "ce:indexed-name": "Danzon PM."
                                }
                            ]},
                            "ref-sourcetitle": "Value Health"
                        },
                        "ce:source-text": "Lakdawalla DN, Doshi JA, Garrison LP Jr, Phelps CE, Basu A, Danzon PM. Defining elements of value in health care-a health economics approach: an ISPOR Special Task Force report [3]. Value Health. 2018;21(2):131-139. doi:10.1016/j.jval.2017.12.007"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Boston",
            "@id": "60104690",
            "affilname": "Harvard Pilgrim Health Care Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60104690",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85139066866",
        "dc:description": "Background: Each country manages access to anticancer drugs differently due to variations in the structure and financing of the health system, but a summary of the various strategies used is absent. This study aimed to review and summarize financing strategies implemented across countries to facilitate access to high-cost anticancer drugs. Methods: We conducted a systematic review of articles referenced in PubMed, Embase, and Web of Science through May 12, 2021. Articles published in the English language from 2000 that describe strategies implemented in different countries to facilitate access to high-cost anticancer drugs were included. Letters, news articles, and proposed strategies were excluded. Quality assessment was not performed as we aimed to summarize the strategies. Data were analyzed by thematic analysis. A review protocol was registered at PROSPERO (CRD42018068616). Results: The review included 204 studies from 176 countries. Three themes of financing strategies were identified: (1) Basic pharmaceutical reimbursement and pricing policies, (2) Alternative funding strategies specific to high-cost drugs, and (3) Financial assistance for individual patients. Access in most countries depends mainly on basic pharmaceutical reimbursement policies (165 of 176 countries). Apart from that, high-income countries (HICs) tended to use funding strategies targeting high-cost drugs (72% of HICs vs 0%-24% of the rest), such as managed entry agreements (MEAs) or dedicated funds for high-cost drugs. In contrast, lower-income countries tended to implement financial assistance programs for cancer patients as a tool to increase access (32% of HICs vs 62%-79% of the rest). Conclusion: Many countries have implemented a combination of strategies to increase access to high-cost anticancer drugs. Most low-and middle-income countries utilized placement of anticancer drugs on a national list of essential medicines and patient assistance programs (PAPs) to facilitate access, while many HICs implemented a broader range of strategies.",
        "prism:coverDate": "2022-09-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85139066866",
        "dc:creator": {"author": [{
            "ce:given-name": "Chanthawat",
            "preferred-name": {
                "ce:given-name": "Chanthawat",
                "ce:initials": "C.",
                "ce:surname": "Patikorn",
                "ce:indexed-name": "Patikorn C."
            },
            "@seq": "1",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Patikorn",
            "@auid": "57214073074",
            "author-url": "https://api.elsevier.com/content/author/author_id/57214073074",
            "ce:indexed-name": "Patikorn C."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85139066866"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85139066866&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85139066866&origin=inward"
            }
        ],
        "source-id": "21100787828",
        "citedby-count": "0",
        "prism:volume": "11",
        "subtype": "re",
        "dc:title": "Financing Strategies to Facilitate Access to High-Cost Anticancer Drugs: A Systematic Review of the Literature",
        "openaccess": "1",
        "prism:issn": "23225939",
        "publishercopyright": "Â© 2022 The Author(s); Published by Kerman University of Medical Sciences.",
        "prism:issueIdentifier": "9",
        "subtypeDescription": "Review",
        "prism:publicationName": "International Journal of Health Policy and Management",
        "prism:pageRange": "1625-1634",
        "prism:endingPage": "1634",
        "openaccessFlag": "true",
        "prism:doi": "10.34172/IJHPM.2021.138",
        "prism:startingPage": "1625",
        "dc:identifier": "SCOPUS_ID:85139066866",
        "dc:publisher": "Kerman University of Medical Sciences"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Antineoplastic Drug"
        },
        {
            "@_fa": "true",
            "$": "Expensive"
        },
        {
            "@_fa": "true",
            "$": "Reimbursement"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Leadership and Management",
            "@code": "2911",
            "@abbrev": "NURS"
        },
        {
            "@_fa": "true",
            "$": "Health (social science)",
            "@code": "3306",
            "@abbrev": "SOCI"
        },
        {
            "@_fa": "true",
            "$": "Health Policy",
            "@code": "2719",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Management, Monitoring, Policy and Law",
            "@code": "2308",
            "@abbrev": "ENVI"
        },
        {
            "@_fa": "true",
            "$": "Health Information Management",
            "@code": "3605",
            "@abbrev": "HEAL"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Chanthawat",
            "preferred-name": {
                "ce:given-name": "Chanthawat",
                "ce:initials": "C.",
                "ce:surname": "Patikorn",
                "ce:indexed-name": "Patikorn C."
            },
            "@seq": "1",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Patikorn",
            "@auid": "57214073074",
            "author-url": "https://api.elsevier.com/content/author/author_id/57214073074",
            "ce:indexed-name": "Patikorn C."
        },
        {
            "ce:given-name": "Suthira",
            "preferred-name": {
                "ce:given-name": "Suthira",
                "ce:initials": "S.",
                "ce:surname": "Taychakhoonavudh",
                "ce:indexed-name": "Taychakhoonavudh S."
            },
            "@seq": "2",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Taychakhoonavudh",
            "@auid": "56196894400",
            "author-url": "https://api.elsevier.com/content/author/author_id/56196894400",
            "ce:indexed-name": "Taychakhoonavudh S."
        },
        {
            "ce:given-name": "Rungpetch",
            "preferred-name": {
                "ce:given-name": "Rungpetch",
                "ce:initials": "R.",
                "ce:surname": "Sakulbumrungsil",
                "ce:indexed-name": "Sakulbumrungsil R."
            },
            "@seq": "3",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Sakulbumrungsil",
            "@auid": "23089392500",
            "author-url": "https://api.elsevier.com/content/author/author_id/23089392500",
            "ce:indexed-name": "Sakulbumrungsil R."
        },
        {
            "ce:given-name": "Dennis",
            "preferred-name": {
                "ce:given-name": "Dennis",
                "ce:initials": "D.",
                "ce:surname": "Ross-Degnan",
                "ce:indexed-name": "Ross-Degnan D."
            },
            "@seq": "4",
            "ce:initials": "D.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60104690",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60104690"
            },
            "ce:surname": "Ross-Degnan",
            "@auid": "7006679299",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006679299",
            "ce:indexed-name": "Ross-Degnan D."
        },
        {
            "ce:given-name": "Puree",
            "preferred-name": {
                "ce:given-name": "Puree",
                "ce:initials": "P.",
                "ce:surname": "Anantachoti",
                "ce:indexed-name": "Anantachoti P."
            },
            "@seq": "5",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Anantachoti",
            "@auid": "6506845858",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506845858",
            "ce:indexed-name": "Anantachoti P."
        }
    ]}
}}